Biogroei SRL
8.7 FTEBiogroei reported total assets of €1.60m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026), with 8.7 full-time equivalents.
The score of Biogroei shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +50 % Total assets +62 % Headcount (avg FTE) +61 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biogroei's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Biogroei's financial analysis
- Solvency64.1%sector median: 49.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biogroei
Biogroei's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0650.847.036
- VAT number
- BE0650847036
- Peppol
- Registered · 0208:0650847036 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Mar 2016
- Registered office
- 3010 Leuven
- Size
- Micro · 8.7 FTE
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Wholesale of fertilisers and agrochemical products (NACE 46852)
Biogroei (SRL) has been based in Leuven since 2016, active in: wholesale of fertilisers and agrochemical products. For 2025, it reports a net profit of 9,983 € and equity of €1.03m; its revenue is not published. With 8.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 64.1%, above the median of its sector (49.9%).
Companies similar to Biogroei
Companies in the same business, of comparable size and area, outside its group.
- Circle Chemicals Manufacture of other inorganic basic chemicals Fleurus · balance sheet €1.60m
- Geerkens BIO & Garden Products Other mining and quarrying n.e.c. Houthalen-Helchteren · balance sheet €2.43m
- Leemans Manufacture of fertilisers and nitrogen compounds Hoogstraten · balance sheet €3.48m
- Activaria Activities of head offices Pelt · balance sheet 48,262 €
- Plantacote Wholesale of chemical products Herentals · balance sheet €3.01m
- Casanova Hornu Activities of agents involved in the wholesale of fuels, ores, metals and industrial chemicals Bernissart · balance sheet €1.51m
- Phytosystem Wholesale of chemical products Kortrijk · balance sheet €2.97m
- Fertiappro Wholesale of chemical products Frasnes-lez-Anvaing · balance sheet €1.37m
Frequently asked questions about Biogroei
What is the revenue of Biogroei?
Biogroei files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biogroei?
In Belgium, the VAT number is the company number prefixed with BE: BE0650847036 for Biogroei, if the company is VAT-registered. Its company number (CBE) is 0650.847.036.
Where is the registered office of Biogroei?
According to the CBE register, the registered office of Biogroei is in 3010 Leuven.
What is the equity of Biogroei?
At the close of the 2025 financial year, the equity of Biogroei amounts to 1,026,922 €, a solvency of 64.1% of total assets.
How many people work at Biogroei?
8.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biogroei?
The register lists 1 active mandates at Biogroei. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biogroei
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →